MENU
NXTC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NextCure (NXTC) Ownership - Who owns NextCure?

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
9000 Virginia Manor Road
Phone
+1 240 399-4900
Employees
40
Web
https://www.nextcure.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.3M
P/E Ratio
N/A
Total Cash
29.74M
Projected Growth
N/A
Total Debt
3.88M
Revenue
N/A
Risk (Beta)
2.35
Dividend Yield
N/A
Total Cash/Share
8.23
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
NXTC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
9000 Virginia Manor Road
Phone
+1 240 399-4900
Employees
40
Web
https://www.nextcure.com